Hakettstown, NJ, United States of America

Alan W Hruza


 

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 132(Granted Patents)


Location History:

  • Hakettstown, NJ (US) (2014)
  • Hackettstown, NJ (US) (1995 - 2019)

Company Filing History:


Years Active: 1995-2025

where 'Filed Patents' based on already Granted Patents

24 patents (USPTO):

Title: The Innovative Contributions of Alan W. Hruza in the Field of Diabetes Treatment

Introduction: Alan W. Hruza, based in Hackettstown, NJ, is a notable inventor with a remarkable portfolio of 23 patents. His work primarily focuses on innovative compounds that are pivotal in the treatment of diabetes and cardiometabolic diseases. Hruza’s inventions have significantly contributed to advancing medical treatments and enhancing patient outcomes.

Latest Patents: Among his latest patents, Hruza has developed compounds that are particularly useful for altering bile acid levels to treat diabetes and cardiovascular diseases. Specifically, these compounds of Formula (I) or pharmaceutically acceptable salts thereof act as Cyp8b1 inhibitors. They hold promise in preventing and treating diabetes, as well as serving as remedial agents for cardiovascular diseases.

Career Highlights: Hruza has held prominent roles in leading pharmaceutical companies including Merck Sharp & Dohme Corporation and Schering Corporation. His extensive experience in these organizations has facilitated the development and patenting of critical new therapies that address significant health challenges.

Collaborations: Throughout his career, Hruza has collaborated with various professionals, including notable coworkers Paul Reichert and Vincent Stewart Madison. These partnerships have enriched his research and innovation processes, allowing for diverse perspectives in tackling complex medical issues.

Conclusion: Alan W. Hruza’s contributions through his patents form a substantial part of the ongoing battle against diabetes and cardiometabolic diseases. His innovative compounds reflect the potential for future breakthroughs in treatment, underscoring the importance of continued research and development in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…